AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)
AbbVie (ABBV) posted quarterly Current Deferred Tax Assets of $1.1 billion for Q3 2015, up 109.92% year-over-year from $524.0 million in Q3 2014, and down 10.35% quarter-over-quarter from $1.2 billion in Q2 2015.
AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
AbbVie (ABBV) has reported Current Deferred Tax Assets for 4 consecutive years, with $1.1 billion the latest figure, recorded in Q3 2015.
- In Q3 2015, Current Deferred Tax Assets rose 109.92% year-over-year to $1.1 billion; the TTM figure through Sep 2015 stood at $1.1 billion (up 109.92% YoY), while the FY2014 annual figure was $896.0 million, up 16.97% from the prior year.
- Current Deferred Tax Assets slipped to $1.1 billion in Q3 2015 per ABBV's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $1.4 billion in Q2 2013 and bottomed at $524.0 million in Q3 2014.
- Historically, Current Deferred Tax Assets has averaged $1.1 billion across 4 years, with a median of $1.1 billion in 2014.
- Annual changes were most pronounced in 2014 — Current Deferred Tax Assets slumped 63.07% — and 2015, when it soared 109.92%.
- AbbVie's Current Deferred Tax Assets stood at $669.0 million in 2012, then rose by 14.5% to $766.0 million in 2013, then increased by 16.97% to $896.0 million in 2014, then gained by 22.77% to $1.1 billion in 2015.
- Business Quant data shows ABBV's Current Deferred Tax Assets at $1.1 billion in Q3 2015, $1.2 billion in Q2 2015, and $1.1 billion in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 1.10 Bn |
| Sep 30, 2015 | 1.10 Bn |
| Jun 30, 2015 | 1.23 Bn |
| Jun 30, 2015 | 1.23 Bn |
| Mar 31, 2015 | 1.06 Bn |
| Mar 31, 2015 | 1.06 Bn |
| Dec 31, 2014 | 896.00 Mn |
| Dec 31, 2014 | 896.00 Mn |
| Sep 30, 2014 | 524.00 Mn |
| Sep 30, 2014 | 524.00 Mn |
| Jun 30, 2014 | 1.10 Bn |
| Jun 30, 2014 | 1.10 Bn |
| Mar 31, 2014 | 1.08 Bn |
| Mar 31, 2014 | 1.08 Bn |
| Dec 31, 2013 | 766.00 Mn |
| Dec 31, 2013 | 766.00 Mn |
| Sep 30, 2013 | 1.42 Bn |
| Sep 30, 2013 | 1.42 Bn |
| Jun 30, 2013 | 1.44 Bn |
| Jun 30, 2013 | 1.44 Bn |